London Daily

Focus on the big picture.
Friday, Jun 20, 2025

UK vaccine strategy 'paying off' as latest trials boost stockpiles

UK vaccine strategy 'paying off' as latest trials boost stockpiles

Pre-ordering of Janssen and Novavax means Britain has procured 247m successfully trialled jabs

Britain has cemented its status as one of the world’s leading buyers of effective Covid vaccines after two more pharmaceutical companies reported positive trial results – potentially growing the UK stockpile by 90m doses.

The US drugmaker Johnson & Johnson announced on Friday that its vaccine – which requires only one dose – is effective. This followed Thursday’s news that the Novavax vaccine, which will be manufactured in the UK, performed well in phase 3 trials.

The UK’s vaccines taskforce has pre-ordered 30m doses of the Janssen vaccine, produced by Johnson and Johnson via its Belgian subsidiary, and 60m Novavax doses, which will be administered as two doses per person if it gets regulatory approval. Both can be stored at fridge temperatures.

In total, the UK has procured 247m vaccine doses from companies with positive phase 3 results: roughly 3.7 jabs per person, Guardian analysis has found. Canada, Chile, Australia and New Zealand are the only countries with a higher rate per head, according to data from Duke Global Health Innovation Center including contracts signed up to 25 January.

While both the US and the EU have procured more than 1bn effective doses each, these numbers equate to lower rates of 3.4 and 2.4 per person. The UK has placed orders for a further 120m vaccines from Sanofi-GSK and Valneva, but these still await positive trial results.

Johnson & Johnson said its vaccine had 72% efficacy in preventing Covid in US trials, but a lower rate of 66% was observed globally in a large trial conducted across three continents and against multiple variants.

It gave people 85% protection against severe illness, even in South Africa, which is struggling with a problematic variant of the virus. The vaccine gave 100% protection against hospitalisation and death, as do the other vaccines now approved.

The health secretary, Matt Hancock, said the news meant the UK was in “pole position” in the race to protect its population against the virus. “Our approach of buying abroad and making here at home is paying off,” he said.

With case rates and hospitalisations still at high levels, ministers are keenly awaiting data on the impact of the vaccine rollout on the spread of the virus, which should begin to emerge in the next fortnight.

Boris Johnson has signalled he will wait until the week of 22 February, when more evidence will be available, before making firm decisions about lifting schools closure or other lockdown measures. The latest NHS figures, published on Friday, showed that 6.8 million people have now received their first dose of Covid vaccine in the UK.

Some health experts are calling on the UK government to consider sharing its vaccine supplies with other countries, including the EU, given the shared imperative of tackling the virus worldwide.


Boris Johnson, seen here at a lab in Scotland that will manufacture a Covid vaccine, will wait until 22 February before considering lifting lockdown measures.


Dr Alberto Giubilini, from the Oxford Uehiro Centre for Practical Ethics at the University of Oxford, said: “I think that the more vaccine doses we have in the UK, the stronger the reason to give some to the EU. It is not just about being generous, it is to make sure that the problem is addressed at the collective level, which is the only level at which it can be addressed if we want long term positive outcomes.”

A government source insisted it was too soon to contemplate whether the UK might have surplus doses, however – pointing out that the two newest vaccines must still await the approval of the regulator. “There is no expectation that we will have excess levels of supply, because of the time lag,” they said.

Vaccine availability remains the constraint on the speed of the immunisation programme, with some regions reporting inconsistent supplies. Hancock has also made clear he believes the public may need to be re-vaccinated in a year’s time, or perhaps sooner, as more evidence emerges about how long protection lasts.

Newsletter

Related Articles

0:00
0:00
Close
16 Billion Login Credentials Leaked in Unprecedented Cybersecurity Breach
Senate hearing on who was 'really running' Biden White House kicks off
Iranian Military Officers Reportedly Seek Contact with Reza Pahlavi, Signal Intent to Defect
FBI and Senate Investigate Allegations of Chinese Plot to Influence the 2020 Election in Biden’s Favor Using Fake U.S. Driver’s Licenses
Vietnam Emerges as Luxury Yacht Destination for Ultra‑Rich
Plans to Sell Dutch Embassy in Bangkok Face Local Opposition
China's Iranian Oil Imports Face Disruption Amid Escalating Middle East Tensions
Trump's $5 Million 'Trump Card' Visa Program Draws Nearly 70,000 Applicants
DGCA Finds No Major Safety Concerns in Air India's Boeing 787 Fleet
Airlines Reroute Flights Amid Expanding Middle East Conflict Zones
Elon Musk's xAI Seeks $9.3 Billion in Funding Amid AI Expansion
Trump Demands Iran's Unconditional Surrender Amid Escalating Conflict
Israeli Airstrike Targets Iranian State TV in Central Tehran
President Trump is leaving the G7 summit early and has ordered the National Security Council to the Situation Room
Taiwan Imposes Export Ban on Chips to Huawei and SMIC
Israel has just announced plans to strike Tehran again, and in response, Trump has urged people to evacuate
Netanyahu Signals Potential Regime Change in Iran
Juncker Criticizes EU Inaction on Trump Tariffs
EU Proposes Ban on New Russian Gas Contracts
Analysts Warn Iran May Resort to Unconventional Warfare
Iranian Regime Faces Existential Threat Amid Conflict
Energy Infrastructure Becomes War Zone in Middle East
UK Home Secretary Apologizes Over Child Grooming Failures
Trump Organization Launches 5G Mobile Network and Golden Handset
Towcester Hosts 2025 English Greyhound Derby Amid Industry Scrutiny
Gary Oldman and David Beckham Knighted in King's Birthday Honours
Over 30,000 Lightning Strikes Recorded Across UK During Overnight Storms
Princess of Wales Returns to Public Duties at Trooping the Colour
Red Arrows Use Sustainable Fuel in Historic Trooping the Colour Flypast
Former Welsh First Minister Addresses Unionist Concerns Over Irish Language
Iran Signals Openness to Nuclear Negotiations Amid Ongoing Regional Tensions
France Bars Israeli Arms Companies from Paris Defense Expo
King Charles Leads Tribute to Air India Crash Victims at Trooping the Colour
Jack Pitchford Embarks on 200-Mile Walk to Support Stem Cell Charity
Surrey Hikers Take on Challenge of Climbing 11 Peaks in a Single Day
UK Deploys RAF Jets to Middle East Amid Israel-Iran Tensions
Two Skydivers Die in 'Tragic Accident' at Devon Airfield
Sainsbury's and Morrisons Accused of Displaying Prohibited Tobacco Ads
UK Launches National Inquiry into Grooming Gangs
Families Seek Closure After Air India Crash
Gold Emerges as Global Safe Haven Amid Uncertainty
Trump Reports $57 Million Earnings from Crypto Venture
Trump's Military Parade Sparks Concerns Over Authoritarianism
Nationwide 'No Kings' Protests Challenge Trump's Leadership
UK Deploys Jets to Middle East Amid Rising Tensions
Trump's Anti-War Stance Tested Amid Israel-Iran Conflict
Germany Holds First Veterans Celebration Since WWII
U.S. Health Secretary Dismisses CDC Vaccine Advisory Committee
Minnesota Lawmaker Melissa Hortman and Husband Killed in Targeted Attack; Senator John Hoffman and Wife Injured
Exiled Iranian Prince Reza Pahlavi Urges Overthrow of Khamenei Regime
×